Effect of α-tocopherol on hepatocarcinogenesis in transforming growth factor-α (TGF-α) transgenic mice treated with diethylnitrosamine

International Journal for Vitamin and Nutrition Research

Volumn 71, Issue 5, 2001, Pages 261-267

  Kakizaki, S ^a   Takagi, H ^a   Fukusato, T ^a   Toyoda, M ^a   Horiguchi, N ^a   Sato, K ^a   Takayama, H ^a   Nagamine, T ^a   Mori, M ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Chemoprevention; Hepatocarcinogenesis; PCNA; Transforming growth factor (TGF ); Vitamin E; tocopherol

Indexed keywords

AGE; ALPHA TOCOPHEROL; ALPHA TOCOPHERYLACETATE; CARCINOGENESIS; CONCENTRATION (PARAMETERS); CYCLINE; DIET; DIETHYLNITROSAMINE; GENE OVEREXPRESSION; LIVER; LIVER CARCINOGENESIS; MALE; NUTRIENT DEFICIENCY; PROPHYLAXIS; TRANSFORMING GROWTH FACTOR ALPHA; TRANSGENIC MOUSE; TUMOR DIAGNOSIS;

ANIMALIA; MUS MUSCULUS;

EID: 0034760007     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.71.5.261     Document Type: Article

References (25)

1. Randomized trial of effects of interferon on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
2. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: A pilot study
3. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
4. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9)
5. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
6. Is vitamin E a useful agent to protect against oxy radical-promoted lung tumorigenesis in ddY mice?
7. Prevention of experimental cancer and immunostimulation by Vitamin E (immunosurveillance)
8. Hepatic tocopherol content in primary hepatocellular carcinoma and liver metastases
9. Vitamin E modulation of dieldrin-induced hepatic focal lesion growth in mice
10. TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas
11. Development of liver tumors in transforming growth factor alpha transgenic mice
12. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice
13. Morphology of potential neoplastic hepatocyte lesions and liver tumors in mice and a comparison with other species
14. Determination of vitamin A, E, and K and ubiquinones in plasma by very high speed liquid chromatography
15. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model
16. Effects of dietary vitamin E on clinical course and plasma glutamic oxaloacetic transaminase and glutamic pyruvic transaminase activities in hereditary hepatitis of LEC rats
17. Lipid peroxidation and antioxidant systems in the liver injury produced by glutathione depleting agents
18. Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis
19. Role of oxidative stress in the selective toxicity of dieldrin in the mouse liver
20. Correlation of repressed transcription of alpha-tocopherol transfer protein with serum alpha-tocopherol during hepatocarcinogenesis
21. Hepatic enzymatic metabolism alterations and oxidative stress during the onset of carcinogenesis: Protective role of alpha-tocopherol
22. Effects of alpha-tocopherol, phenobarbital, and butylated hydroxyanisole during promotion of diethylnitrosamine-initiated rat hepatocarcinogenesis
23. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesion initiated by N-nitrosodiethylamine and promoted by phenobarbital
24. Absorption, transport and metabolism of vitamin E
25. Dietary hydrogen peroxide enhances hepatocarcinogenesis in trout: Correlation with 8-hydroxy-2′-deoxyguanosine levels in liver DNA